These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3887922)

  • 1. End-stage renal disease in Michigan. Incidence, underlying causes, prevalence, and modalities of treatment.
    Weller JM; Wu SC; Ferguson CW; Hawthorne VM
    Am J Nephrol; 1985; 5(2):84-95. PubMed ID: 3887922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study).
    Julius M; Kneisley JD; Carpentier-Alting P; Hawthorne VM; Wolfe RA; Port FK
    Arch Intern Med; 1989 Apr; 149(4):839-42. PubMed ID: 2705834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the Caribbean renal registry, 2006.
    Soyibo AK; Barton EN
    West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
    Costenbader KH; Desai A; Alarcón GS; Hiraki LT; Shaykevich T; Brookhart MA; Massarotti E; Lu B; Solomon DH; Winkelmayer WC
    Arthritis Rheum; 2011 Jun; 63(6):1681-8. PubMed ID: 21445962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease among HIV-infected adults in North America.
    Abraham AG; Althoff KN; Jing Y; Estrella MM; Kitahata MM; Wester CW; Bosch RJ; Crane H; Eron J; Gill MJ; Horberg MA; Justice AC; Klein M; Mayor AM; Moore RD; Palella FJ; Parikh CR; Silverberg MJ; Golub ET; Jacobson LP; Napravnik S; Lucas GM;
    Clin Infect Dis; 2015 Mar; 60(6):941-9. PubMed ID: 25409471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
    Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
    Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year mortality rates in US children with end-stage renal disease.
    Chavers BM; Molony JT; Solid CA; Rheault MN; Collins AJ
    Am J Nephrol; 2015; 41(2):121-8. PubMed ID: 25766310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975-1984.
    Kappel DF; Van Tuinen M
    Am J Kidney Dis; 1986 Oct; 8(4):234-8. PubMed ID: 3766529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates.
    Julius M; Hawthorne VM; Carpentier-Alting P; Kneisley J; Wolfe RA; Port FK
    Am J Kidney Dis; 1989 Jan; 13(1):61-9. PubMed ID: 2643311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland.
    Helanterä I; Haapio M; Koskinen P; Grönhagen-Riska C; Finne P
    Am J Kidney Dis; 2012 May; 59(5):700-6. PubMed ID: 21958597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.